Page last updated: 2024-10-31

nocodazole and Ewing Sarcoma

nocodazole has been researched along with Ewing Sarcoma in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment of nocodazole-synchronized cells with JNJ-7706621 was able to override mitotic arrest by preventing spindle checkpoint signaling, resulting in failure of chromosome alignment and segregation."1.38Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases. ( Hara, A; Kawai, G; Kimura, M; Matsuhashi, A; Nagano, A; Ohno, T; Okano, Y; Saio, M; Saitou, M; Shimizu, K; Takigami, I; Yamada, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuhashi, A1
Ohno, T1
Kimura, M1
Hara, A1
Saio, M1
Nagano, A1
Kawai, G1
Saitou, M1
Takigami, I1
Yamada, K1
Okano, Y1
Shimizu, K1

Other Studies

1 other study available for nocodazole and Ewing Sarcoma

ArticleYear
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Current cancer drug targets, 2012, Volume: 12, Issue:6

    Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Bone Neoplasms; Ce

2012